Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
5.66
-0.17 (-2.92%)
At close: Mar 20, 2026, 4:00 PM EDT
5.77
+0.11 (1.94%)
After-hours: Mar 20, 2026, 4:00 PM EDT
Addex Therapeutics Employees
Addex Therapeutics had 2 employees as of December 31, 2024. The number of employees decreased by 21 or -91.30% compared to the previous year.
Employees
2
Change (1Y)
-21
Growth (1Y)
-91.30%
Revenue / Employee
$99,412
Profits / Employee
-$3,823,143
Market Cap
6.91M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 2 | -21 | -91.30% |
| Dec 31, 2023 | 23 | -1 | -4.17% |
| Dec 31, 2022 | 24 | -2 | -7.69% |
| Dec 31, 2021 | 26 | -1 | -3.70% |
| Dec 31, 2020 | 27 | 8 | 42.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 117 |
| NuCana | 22 |
| Cardio Diagnostics Holdings | 15 |
| Alzamend Neuro | 7 |
| Creative Medical Technology Holdings | 4 |
| PharmaCyte Biotech | 2 |
| Xenetic Biosciences | 2 |
| SciSparc | 2 |
ADXN News
- 6 weeks ago - Addex Therapeutics (ADXN) Publishes Promising Research on Anxiety Treatment - GuruFocus
- 2 months ago - Addex Therapeutics (ADXN) Advances NTX-253 into Clinical Trials for Schizophrenia - GuruFocus
- 2 months ago - Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia - GlobeNewsWire
- 3 months ago - Addex Amends its at the Market Offering Agreement With H.C. Wainwright & Co. - GlobeNewsWire
- 3 months ago - Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Highlights: Strategic Advances Amidst ... - GuruFocus
- 3 months ago - Q3 2025 Addex Therapeutics Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - Earnings Scheduled For December 4, 2025 - Benzinga
- 3 months ago - Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update - GlobeNewsWire